Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Solid synthetic organic polymer
Patent
1995-04-25
1997-06-17
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Solid synthetic organic polymer
514773, 514777, 514784, 514887, 424 59, 424434, 424445, 424401, 424487, A61K 740
Patent
active
056397950
ABSTRACT:
The invention relates to methods for the treatment of gingivitis, oral plaque and oral or dermatological fungal infections by the administration of a liquid methacrylic acid copolymer composition that contains a release adjusting agent and a pharmacological agent. The composition forms a solid film upon drying, and is capable of accomplishing the sustained release of the pharmacological agent such as to permit its use in the treatment or prevention of dental or dermatological conditions.
REFERENCES:
patent: 2984639 (1961-05-01), Stamberger et al.
patent: 3325402 (1967-06-01), Erskine
patent: 3925895 (1975-12-01), Kliment et al.
patent: 4374824 (1983-02-01), Wahmi
patent: 4517173 (1985-05-01), Kizawa et al.
patent: 4539199 (1985-09-01), Orban et al.
patent: 4554156 (1985-11-01), Fischer et al.
patent: 4569837 (1986-02-01), Suzuki et al.
patent: 4683134 (1987-07-01), Palinczar
patent: 4725440 (1988-02-01), Ridgeway et al.
patent: 4925660 (1990-05-01), Atsuta et al.
patent: 4957730 (1990-09-01), Bohn et al.
patent: 5002769 (1991-03-01), Friedman et al.
patent: 5023082 (1991-06-01), Friedman et al.
patent: 5160737 (1992-11-01), Friedman et al.
patent: 5330746 (1994-07-01), Friedman et al.
patent: 5438076 (1995-08-01), Friedman et al.
Bossche, H. V. et al., "Anti-Candida Drugs--The Biochemical Basis for Their ctivity," Crit. Rev. Microbiol. 15(1):57-72 (Nov. 1987).
Chafi, N. et al., "Preparation and Study of Oral Galenic Forms by Dispersing into Eudragit/Matrix a Polyacryloyl-Acetylsalicylic Anhydride," Drug Dev. Industrial Pharm. 15(4):629-648 (Apr. 1989).
Dittgen, M. et al., "Untersuchung von Polyacrylat-und Polymethacrylathydrogelen," Pharmazie 41:883-884 (1986).
Translation of Dittgen, M. et al., "Untersuchung von Polyacrylat-und Polymethacrylathydrogelen," Pharmazie 41:883-884 (1986) (document AR2).
Friedman, M. et al., "Sustained Release Chlorhexidine Preparations for Topical Use," IADR Abstr. p. 905, Abstract 72 (1980).
Kostiala, I. et al., "Oral mycoses and their treatment," Acta Ondontol. Scand. 37:87-101 (1979).
Rohm Pharma GmBh, Manufacturer's Listing of Different Types of Eudragit.TM., Weiderstadt, Germany Jan. 1970.
Rohm Pharma GmBh, "Standards Sheet (Info L/S-7a/e) Eudragit.RTM. L/S", Weiderstadt, Germany Jan. 1970.
Rohm Pharma GmBh, "Technical Application Pamphlet (Info L/S-13/e) Eudragit.RTM. L/S", Weiterstadt, Germany Jan. 1991.
Rohm Pharma GmBh, "Eudragit.TM. RL and RS Application in the Production of Pharmaceutical Preparations" Jan. 1991.
Von W. Kern, B. et al., in: Hagers Handbuch Der Pharmazeutischen Praxis, Springer-Verlag: Berlin, pp. 402-403 (1977).
Translation of Von W. Kern, B. et al., in: Hagers Handbuch Der Pharmazeutischen Praxis, Springer-Verlag: Berlin, pp. 402-403 (1977) (document AR6).
Derwent English Language abstract for DE 35 44983 (document AL4), WPI Acc. No. 87-178557/26 6 Jan. 1996.
Derwent English Language abstract for JP 63 044518 (document AO4), WPI Acc. No. 88-094610/14 Feb. 1994.
Derwent English Language abstract for JP 60 228410, WPI Acc. No. 86-003017/01 Feb. 1994.
Derwent English Language abstract for DE 2 332 383 (Document AL2), WPI Acc. No. 74-04404V/03 Jan. 1996.
Derwent English Language abstract for JP 63 60924 (Document AM4), WPI Acc. No. 88-092984 Jan. 1996.
Chang, R.K., et al., "Preparation and Preliminary Evaluation of Eudragit RL and RS Pseudolatices for Controlled Drug Release," Drug Development and Industrial Pharmacy 15(3):361-372 (1989).
Goto, S., et al., "Evaluation of the Sustained Release Properties of Eudragit RS, RL and S (acrylic resins) Microcapsule Containing Ketoprofen in Beagle Dogs," J. Microencapsulation 5:343-360 (Oct.-Dec. 1988).
Kristl, J. et al., "Physikalische Eiqenschaften von Eudispert-Poly-elektrolytsystemen und ihre In-Vitro-Wirkstoffliberation," Acta Pharm. Technol. 33(3): 140-144 (Sep. 1987).
Translation of Kristl, J. et al., "Physikalische Eiqenschaften von Eudispert-Poly-elektrolytsystemen und ihre In-Vitro-Wirkstoffliberation," Acta Pharm. Technol. 33(3): 140-144 (Sep. 1987) (Ref. AT3).
Thoennes, C.J., et al., "Evaluation of a Rapidly Disintegrating Moisture Resistant Lacquer Film Coating," Drug Development and Industrial Pharmacy 15(2):165-185 (1989).
Wood, D.A., et al., "Biodegradable Drug Delivery Systems," International J. of Pharmaceutics 7:1-18 (1980).
Derwent Abstract for German Patent Document No. 3720147 (Ref. AP4), WPI Acc. No. 89-008242 Jan. 1987.
Derwent Abstract for the Patent Family of European Patent Document No. EP 0298271 (Ref. AL5), WPI Acc. No. 89-008242 Jun. 1987.
Friedman Michael
Sintov Amon
Page Thurman K.
Perio Products Ltd.
Spear James M.
Yissum Research Development Company of the Hebrew University of
LandOfFree
Liquid polymer composition, and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid polymer composition, and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid polymer composition, and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158280